Jubilant Pharmova Ltd (JUBLPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 525933, "name": "Jubilant Pharmo", "stock_name": "Jubilant Pharmo", "full_name": "Jubilant Pharmova Ltd", "name_url": "stocks-analysis/jubilant-pharmo", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,069.00", "chg": 19.55, "chgp": "1.86%", "dir": 1, "prev_price": "1,049.45", "mcapval": "17,027.15 Cr", "mcap": "Small Cap", "scripcode": 530019, "symbol": "JUBLPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE700A01033", "curr_date": "Sep 22, 04:01 PM", "curr_time": "16:30 PM", "last_traded_at": "Sep 22, 04:01 PM IST", "bse_nse_vol": "2.04 lacs", "exc_status": "Active", "traded_date": "Sep 22, 2026", "traded_date_str": "2026 09 22", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jubilant-pharmo-525933-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4200297", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4200297.png", "date": "2026-09-22 08:03:38", "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on longer-term indicators, the stock’s daily moving averages and recent price action suggest caution for investors amid mixed technical readings and a recent downgrade in its Mojo Grade to Sell." }, { "title": "Jubilant Pharmova Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4199046", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4199046.png", "date": "2026-09-21 08:01:43", "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.44% daily gain to ₹1,067.15, alongside mixed readings from MACD, RSI, and moving averages, suggests a cautious but potentially stabilising outlook for this pharmaceuticals and biotechnology small-cap." }, { "title": "Jubilant Pharmova Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-4190960", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_mojoScore_4190960.png", "date": "2026-09-12 10:10:36", "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Jubilant Pharmova Ltd Sees Technical Momentum Shift Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4185581", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4185581.png", "date": "2026-09-08 08:03:42", "description": "Jubilant Pharmova Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early September 2026. Despite a day gain of 3.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, price momentum, and how these factors compare with broader market trends and the pharmaceutical sector." }, { "title": "Jubilant Pharmova Gains 4.73%: Valuation Upgrades and Mixed Financial Signals Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-gains-473-valuation-upgrades-and-mixed-financial-signals-shape-the-week-4183873", "imagepath": "", "date": "2026-09-05 17:06:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> MarketsMOJO upgrades Jubilant Pharmova Ltd rating to Sell on improved valuation</p>\n <p><strong>1 Sep:</strong> Stock surges 2.95% amid valuation upgrade and relative sector appeal</p>\n <p><strong>2 Sep:</strong> Valuation metrics show improvement despite mixed market returns</p>\n <p><strong>4 Sep:</strong> Stock closes the week at Rs.923.75, up 1.92% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.882.05</div></div>\n <div class=\"stat-item\"><div class=..." }, { "title": "Jubilant Pharmova Ltd Valuation Improves Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-valuation-improves-amid-mixed-market-returns-4178374", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_valuationdot_4178374.png", "date": "2026-09-02 08:00:49", "description": "Jubilant Pharmova Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging year-to-date performance relative to the broader Sensex. This article analyses the recent changes in key valuation metrics, compares the company’s standing against its pharmaceutical peers, and assesses the implications for investors navigating the small-cap pharmaceutical sector." }, { "title": "Jubilant Pharmova Ltd Upgraded to Sell on Improved Valuation Amid Mixed Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-upgraded-to-sell-on-improved-valuation-amid-mixed-financial-trends-4177035", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_mojoScore_4177035.png", "date": "2026-09-01 08:10:08", "description": "Jubilant Pharmova Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 31 August 2026, primarily driven by a significant improvement in its valuation metrics. Despite ongoing financial headwinds and underperformance relative to the broader market, the stock’s more attractive valuation profile has prompted a reassessment of its investment appeal." }, { "title": "Jubilant Pharmova Gains 0.33%: Valuation Shift Amid Financial Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-gains-033-valuation-shift-amid-financial-challenges-4174607", "imagepath": "", "date": "2026-08-29 17:04:39", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>24 Aug:</strong> Stock opens at Rs.902.80 with a strong 2.69% gain</p>\n <p><strong>25 Aug:</strong> Downgrade to Strong Sell by MarketsMOJO announced</p>\n <p><strong>25 Aug:</strong> Valuation shifts from very attractive to attractive</p>\n <p><strong>28 Aug:</strong> Week closes at Rs.882.05, up 0.36% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.879.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.882.05</div>..." }, { "title": "Jubilant Pharmova Ltd Downgraded to Strong Sell Amid Financial and Market Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-downgraded-to-strong-sell-amid-financial-and-market-challenges-4168271", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JubilantPharmov_mojoScore_4168271.png", "date": "2026-08-25 08:02:01", "description": "Jubilant Pharmova Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 24 August 2026, reflecting a nuanced shift in valuation metrics despite ongoing financial headwinds. The company’s valuation grade improved from very attractive to attractive, yet deteriorating financial trends and technical indicators continue to weigh heavily on investor sentiment." } ], "total": 433, "sid": "525933", "stock_news_url": "https://www.marketsmojo.com/news/jubilant-pharmova-525933" }, "announcements": [ { "caption": "Update On USFDA Spokane", "datetime": "11-Sep-2026", "details": "Update on USFDA Spokane", "source": "BSE" }, { "caption": "Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST", "datetime": "01-Sep-2026", "details": "Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST", "source": "BSE" }, { "caption": "Receipt Of Show Cause Notice - Jubilant Generics Limited", "datetime": "28-Aug-2026", "details": "Receipt of Show Cause Notice - Jubilant Generics Limited", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 24 Jul 26", "dt": "2026-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06", "dt": "2006-03-17", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

31 Aug: MarketsMOJO upgrades Jubilant Pharmova Ltd rating to Sell on improved valuation

1 Sep: Stock surges 2.95% amid valuation upgrade and relative sector appeal

2 Sep: Valuation metrics show improvement despite mixed market returns

4 Sep: Stock closes the week at Rs.923.75, up 1.92% on the day

Week Open

Rs.882.05

Read full news article

Jubilant Pharmova Ltd Valuation Improves Amid Mixed Market Returns

2026-09-02 08:00:49

Jubilant Pharmova Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging year-to-date performance relative to the broader Sensex. This article analyses the recent changes in key valuation metrics, compares the company’s standing against its pharmaceutical peers, and assesses the implications for investors navigating the small-cap pharmaceutical sector.

Read full news article

Jubilant Pharmova Ltd Upgraded to Sell on Improved Valuation Amid Mixed Financial Trends

2026-09-01 08:10:08

Jubilant Pharmova Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 31 August 2026, primarily driven by a significant improvement in its valuation metrics. Despite ongoing financial headwinds and underperformance relative to the broader market, the stock’s more attractive valuation profile has prompted a reassessment of its investment appeal.

Read full news article

Jubilant Pharmova Gains 0.33%: Valuation Shift Amid Financial Challenges

2026-08-29 17:04:39

Key Events This Week

24 Aug: Stock opens at Rs.902.80 with a strong 2.69% gain

25 Aug: Downgrade to Strong Sell by MarketsMOJO announced

25 Aug: Valuation shifts from very attractive to attractive

28 Aug: Week closes at Rs.882.05, up 0.36% on the day

Read full news article

Jubilant Pharmova Ltd Downgraded to Strong Sell Amid Financial and Market Challenges

2026-08-25 08:02:01

Jubilant Pharmova Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 24 August 2026, reflecting a nuanced shift in valuation metrics despite ongoing financial headwinds. The company’s valuation grade improved from very attractive to attractive, yet deteriorating financial trends and technical indicators continue to weigh heavily on investor sentiment.

Read full news article

View All News